Candesartan
Compound with spectra: 19 MS (LC)
| SpectraBase Compound ID | DQC7Tam32KX |
|---|---|
| InChI | InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29) |
| InChIKey | HTQMVQVXFRQIKW-UHFFFAOYSA-N |
| Mol Weight | 440.46 g/mol |
| Molecular Formula | C24H20N6O3 |
| Exact Mass | 440.159689 g/mol |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Wissenbach/Weber, Saarland University |
| Technique | ITMS |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
| Copyright | Copyright © 2012-2025 Herbert Oberacher. All Rights Reserved. |
|---|---|
| Source of Spectrum | Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria |
| Technique | Q-TOF |
- Candesartan MS2
- Candesartan_neg
- 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Methyl 1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
4'-{[5-(2-Butyl-3-(2-trifluoromethylphenyl))-2,1,3,4-1H-thiatriazol-2-on-1-yl]methyl}biphenyl-2-tetrazole
1-Benzyl-4-{1-[(2,5-dimethylphenyl)methyl]-1H-1,3-benzodiazol-2-yl}pyrrolidin-2-one
Olmesartan artifact (+ME) isomer 1 MS2
14H-Naphtho[1',2':5,6][1,3]oxazino[3,2-a]benzimidazole
Methanesulfonic acid 2-Butyl-6-oxo-5-phenethyl-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-1,6-dihydro-pyrimidin-4-yl ester
(2RS,4SR)-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDRO-PYRIMIDO-[1,2-A]-BENZIMIDAZOLE-2-OL-HYDROCHLORIDE
2-Pyrrolidinone, 4-[1-[(4-fluorophenyl)methyl]-1H-1,3-benzimidazol-2-yl]-1-(3-methylphenyl)-
N-{1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl}-1,3-diphenyl-1H-pyrazole-4-carboxamide
1H-1,3-Benzimidazole, 2-[[(2-chloro-6-fluorophenyl)methoxy]phenylmethyl]-1-[(2-chloro-6-fluorophenyl)methyl]-
This compound is available in the following databases:
Wiley Registry of Tandem Mass Spectral Data: MS for ID
Author: Herbert Oberacher, Institute of Legal Medicine, Innsbruck/Austria
The Wiley Registry® of Tandem Mass Spectral Data: MS for ID contains 10,000 positive and negative mode spectra of over 1200 compounds of interest for forensics, toxicology, and pathology. Learn more.
Maurer, Meyer, Helfer, Weber: LC-HR-MS & MS Library of Drugs, Poisons, and Their Metabolites
Author: Hans H. Maurer, Markus Meyer, Andreas G. Helfer, Armin A. Weber
Developed by toxicologist Hans H. Maurer and his team, the Maurer/Meyer/Helfer/Weber LC-HR-MS/MS Library of Drugs, Poisons, and Their Metabolites consists of spectra for parent drugs or poisons, and their metabolites or artifacts, in various compound classification groups. This metabolite-based library helps minimize the risk of false negative LC-MS results. Learn more.